# Terazosin Hydrochloride

NDC: 24689-855
Generic name: Terazosin Hydrochloride
Labeler / Manufacturer: Apnar Pharma LP
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20200630

FDA application: ANDA074823

## Active ingredients

- TERAZOSIN HYDROCHLORIDE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24689-855"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24689-855
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9176551-3da9-34c1-e053-2995a90a3aee